CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Lazarettgasse 14, AKH BT 25.3, 1090, Vienna, Austria.
Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic.
Nat Commun. 2017 Nov 1;8(1):1238. doi: 10.1038/s41467-017-01439-x.
Maintenance of genome integrity via repair of DNA damage is a key biological process required to suppress diseases, including Fanconi anemia (FA). We generated loss-of-function human haploid cells for FA complementation group C (FANCC), a gene encoding a component of the FA core complex, and used genome-wide CRISPR libraries as well as insertional mutagenesis to identify synthetic viable (genetic suppressor) interactions for FA. Here we show that loss of the BLM helicase complex suppresses FANCC phenotypes and we confirm this interaction in cells deficient for FA complementation group I and D2 (FANCI and FANCD2) that function as part of the FA I-D2 complex, indicating that this interaction is not limited to the FA core complex, hence demonstrating that systematic genome-wide screening approaches can be used to reveal genetic viable interactions for DNA repair defects.
通过修复 DNA 损伤来维护基因组完整性是抑制疾病(包括范可尼贫血症,FA)所必需的关键生物学过程。我们生成了功能丧失的人类单倍体细胞,用于 FA 补体组 C(FANCC),该基因编码 FA 核心复合物的一个组成部分,并使用全基因组 CRISPR 文库和插入诱变来鉴定 FA 的合成可行(遗传抑制剂)相互作用。在这里,我们表明 BLM 解旋酶复合物的缺失可抑制 FANCC 表型,并且我们在 FA 补体组 I 和 D2(FANCI 和 FANCD2)缺陷细胞中证实了这种相互作用,FA 补体组 I 和 D2 作为 FA I-D2 复合物的一部分发挥作用,表明这种相互作用不仅限于 FA 核心复合物,因此表明系统的全基因组筛选方法可用于揭示 DNA 修复缺陷的遗传可行相互作用。